ACT MEMANTINE
As listed in the register: ACT MEMANTINE
5 mg · tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Memantine Hydrochloride
- Made by
- Teva Canada Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (memantine hydrochloride). It describes the substance, not this exact product.
Persistent activation of central nervous system N-methyl-D-aspartate (NMDA) receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease.
Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels.
Effect of Memantine Hydrochloride on the Metabolism of Other Drugs In vitro studies conducted with marker substrates of CYP450 enzymes (CYP1A2, -2A6, -2C9, 2D6, -2E1, -3A4) showed minimal inhibition of these enzymes by memantine.
Food has no effect on the absorption of memantine.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-20
Safety of the active substance
From the US prescribing label for the same active substance (memantine hydrochloride). It describes the substance, not this exact product.
- Memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation.
Most common adverse reactions (≥ 5 % and greater than placebo) are dizziness, headache, confusion and constipation.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States34 matching products
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
Netherlands5 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Teva Canada Limited |
|---|---|
| Active substance | Memantine Hydrochloride |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 5 mg |
| Form | tablet |
| Classification | N06DX01 · Pain, sleep, mood, epilepsy and the brain |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02324059 |
| DPD drug code | 80954 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 5 mg
- 10 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.